U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07696767) titled 'Efficacy and Safety of MegaLT Injection for Platelet Recovery After Umbilical Cord Blood Transplantation' on July 04.
Brief Summary: This is a single-arm, early safety and feasibility exploratory study to evaluate the efficacy and safety of MegaLT Injection in promoting platelet recovery after umbilical cord blood transplantation. Adults with malignant hematologic diseases who undergo umbilical cord blood transplantation will receive a single intravenous infusion of MegaLT Injection on day 14 after transplantation. Two dose levels will be evaluated sequentially, and platelet recovery, platelet transfusion requirements, and safety ou...